The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?

Djavan, 2001, Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?, J Urol, 166, 1679, 10.1016/S0022-5347(05)65652-2 McNeal, 1988, Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread, Am J Surg Pathol, 12, 897, 10.1097/00000478-198812000-00001 Merrick, 2007, Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy, Eur Urol, 52, 715, 10.1016/j.eururo.2007.02.041 Park, 2008, Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy, Invest Radiol, 43, 789, 10.1097/RLI.0b013e318183725e Hambrock, 2010, Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen, J Urol, 183, 520, 10.1016/j.juro.2009.10.022 Puech, 2009, Dynamic contrast-enhanced–magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens, Urology, 74, 1094, 10.1016/j.urology.2009.04.102 Villers, 2006, Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings, J Urol, 176, 2432, 10.1016/j.juro.2006.08.007 Mabjeesh, 2012, High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy, BJU Int, 110, 993, 10.1111/j.1464-410X.2012.10972.x Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y Barzell, 2007, Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate—a 4-year experience, Urology, 70, 27, 10.1016/j.urology.2007.06.1126 Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1 c) prostate cancer, J Am Med Assoc, 271, 368, 10.1001/jama.1994.03510290050036 Bastian, 2004, Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis, Cancer, 101, 2001, 10.1002/cncr.20586 Epstein, 2005, The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1 Karram, 2011, Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings, Am J Surg Pathol, 35, 1351, 10.1097/PAS.0b013e3182217b79 Kirkham, 2006, How good is MRI at detecting and characterising cancer within the prostate?, Eur Urol, 50, 1163, 10.1016/j.eururo.2006.06.025 Merrick, 2007, Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy, Eur Urol, 52, 715, 10.1016/j.eururo.2007.02.041 Portalez, 2012, Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients, Eur Urol, 62, 986, 10.1016/j.eururo.2012.06.044 Franiel, 2011, Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding—multiparametric MR imaging for detection and biopsy planning, Radiology, 259, 162, 10.1148/radiol.10101251 Arumainayagam, 2013, Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard, Radiology, 268, 761, 10.1148/radiol.13120641 Bittner, 2013, Incidence and pathologic features of prostate cancer detected on transperineal template-guided mapping biopsy following negative transrectal ultrasound-guided biopsy, J Urol, 190, 509, 10.1016/j.juro.2013.02.021 Ahmed, 2011, Characterizing clinically significant prostate cancer using template prostate mapping biopsy, J Urol, 186, 458, 10.1016/j.juro.2011.03.147